Table 2 Sensitivity analyses for the baseline physical activity and Aβ interaction on longitudinal tau and cognitive decline
From: Physical activity as a modifiable risk factor in preclinical Alzheimer’s disease
ITC tau | PACC5 | CDR-SOB | |||||||
|---|---|---|---|---|---|---|---|---|---|
n | Estimate | P value | n | Estimate | P value | n | Estimate | P value | |
Primary analyses | 172 | −0.13 [−0.19 to −0.06] | <0.001 | 296 | 0.10 [0.05 to 0.16] | <0.001 | 296 | −0.14 [−0.22 to −0.05] | 0.001 |
Sensitivity analyses | |||||||||
Excluding days under 1,000 steps | 161 | −0.10 [−0.16 to −0.04] | <0.001 | 280 | 0.10 [0.04 to 0.15] | <0.001 | 280 | −0.13 [−0.21 to −0.05] | 0.002 |
Using non-PVC PET data | 172 | −0.09 [−0.15 to −0.03] | 0.006 | 296 | 0.10 [0.04 to 0.16] | <0.001 | 296 | −0.14 [−0.22 to −0.06] | <0.001 |
Including only age <70 | 87 | −0.27 [−0.36 to −0.18] | <0.001 | 124 | 0.24 [0.16 to 0.32] | <0.001 | 124 | −0.36 [−0.45 to −0.27] | <0.001 |
Adjusting for season, self-reported physical activity, FHS-CVD, and GDS | 130 | −0.10 [−0.17 to −0.04] | 0.003 | 244 | 0.10 [0.04 to 0.16] | <0.001 | 244 | −0.13 [−0.22 to −0.04] | 0.003 |
Excluding mild cognitive impairment within 2 years | 171 | −0.12 [−0.18 to −0.05] | <0.001 | 280 | 0.10 [0.04 to 0.16] | <0.001 | 280 | −0.11 [−0.19 to −0.02] | 0.01 |
Adjusting for baseline outcome measure | 172 | −0.08 [−0.13 to −0.02] | 0.007 | 296 | 0.10 [0.04 to 0.16] | <0.001 | 296 | −0.14 [−0.22 to −0.06] | <0.001 |